Colfax Corporation (CFX) PT Lowered to $30 at Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CFX Hot Sheet
Rating Summary:
14 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
Cowen analyst Joseph Giordano lowered the price target on Colfax Corporation (NYSE: CFX) to $30.00 (from $40.00) while maintaining a Outperform rating.
Giordano commented, "Shares reacted harshly to the Nov 19 announcement of the $3+B transformative DJO acquisition that gives CFX a new healthcare platform. With details emerging on the transaction financing (scant initially), we see a case for 50% upside using pro forma full year 2019 estimates. PT to $30 on pro forma 2019 sum of the parts analysis (~10x pro forma 2019E EV/EBITDA)."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cinemark Holdings (CNK) PT Raised to $45 at StoneX
- Freshworks Inc (FRSH) PT Raised to $17 at UBS
- Bruker (BRKR) PT Raised to $70 at Jefferies
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Cowen & Co, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
